BRCA1 and ovarian carcinoma: Furtherly, this study also evaluates the proportion of HRD status in Chinese ovarian cancer patients, the correlation between HRD scores and BRCA1/2 mutations, and its correlation with the efficacy of platinum-containing chemotherapy.